Close

Valeant Pharma (VRX) Completes Amendment to Credit Agreement

March 28, 2017 5:33 PM EDT Send to a Friend
Valeant Pharma (NYSE: VRX) disclosed in an SEC filing:Credit Agreement AmendmentOn March 28, 2017, Valeant Pharmaceuticals International, Inc. (the “Company”) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login